Aetion logo

Aetion

Leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.

6

Funding Rounds

$230.6m

Money raised

Overview

Leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.

Funding

Funding series

Funding Series Analysis

The company Aetion has raised a total of $167.2m in funding over 6 rounds.

Key Insights:

  • Aetion Series C round, May 2021: $110m
  • Aetion Series B round, August 2020: $19m
  • Aetion Series B round, February 2019: $27m
  • Aetion Series A round, March 2017: $11.2m
  • Aetion funding round, February 2019: $27m
  • Aetion funding round, April 2018: $36.4m
Aetion logo
Aetion Series C round, May 2021 $110m
Aetion logo
Aetion Series B round, August 2020 $19m
Aetion logo
Aetion Series B round, February 2019 $27m
Aetion logo
Aetion Series A round, March 2017 $11.2m
Aetion logo
Aetion funding round, February 2019 $27m
Aetion logo
Aetion funding round, April 2018 $36.4m

Industries

Aetion is active in the following industries:
  • Drug discovery
  • Finance
  • Financial technology
  • Technology
  • Biopharmaceutical
  • Analytics
  • Medical device
  • Healthcare
  • Software
  • Customer relationship management (CRM)
  • Therapeutics
  • Health technology
  • Digital therapeutics